The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
复制标题
妇女健康倡议;
DOI:
10.1002/cncr.33261
复制
发表时间:
2021
期刊:
影响因子:
6.2
通讯作者:
Wachtel,MitchellS
中科院分区:
文献类型:
--
作者:
Wachtel,MitchellS
For Black women, a nonsignificant, slow rate decline for 1992 through 2005 of-0.2 APC was followed by a significant, moderate rise in the rate for 2005 through 2012 of 1.1 APC, and a significant, rapid decline in the rate for 2012 through 2017 of-2.0 APC. A joinpoint regression analysis of hormone replacement therapy (HRT) prescription data from the Medical Expenditure Panel Survey4 found 2 significant, extremely rapid declines in prescriptions for women aged >= 50 years:-26.2 APC for 2001 through 2004 and-10.3 APC for 2004 through 2012. The analysis performed in that study, 4 which was not of mammary carcinoma rates in toto but rather of invasive ductal carcinoma rates and invasive lobular carcinoma rates, found no relationship between those rates and HRT prescriptions.[Extracted from the article]Copyright of Cancer (0008543X) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.